Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Gunnar Norkrans

Adjunct Professor

Gunnar Norkrans
Adjunct Professor
gunnar.norkrans@infect.gu.se
+46 31-343 4248

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: SU/Östra , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR
Simon B. Larsson, Gianluca Tripodi, G. Raimondo, C. Saitta, Gunnar Norkrans et al.
Journal of Medical Virology, Journal article 2018
Journal article

PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
J. F. Hansen, M. J. Nielsen, Kristina Nyström, D. J. Leeming, Martin Lagging et al.
Scandinavian Journal of Gastroenterology, Journal article 2018
Journal article

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.
Martin Lagging, Rune Wejstål, Gunnar Norkrans, Olle Karlström, Soo Aleman et al.
Infectious diseases (London, England), Journal article 2017
Journal article

Showing 31 - 40 of 64

2011

2010

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.
Peter Derek Christian Leutscher, Martin Lagging, Mads Rauning Buhl, Court Pedersen, Gunnar Norkrans et al.
Hepatology, Journal article 2010
Journal article

Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
Åsa Alsiö, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl et al.
Clinical infectious diseases , Journal article 2010
Journal article

2008

Treatment of chronic hepatitis B infection: an update of Swedish recommendations
Magnus Lindh, Ingrid Uhnoo, J Bläckberg, AS Duberg, Styrbjörn Friman et al.
Scandinavian Journal of Infectious Diseases, Journal article 2008
Journal article

Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl et al.
Hepatology (Baltimore, Md.), Journal article 2008
Journal article

Showing 31 - 40 of 64

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?